SGS acquires the M-Scan Group
M-Scan is a world leading group of chemical analysis laboratories specialized in advanced chemical and biochemical testing as well as high-end GLP/GMP contract analytical services, consultancy and training based on Mass Spectrometry and Chromatography.
M-Scan's laboratories provide analytical services in the area of Life Science, including protein/glycoprotein analysis, pharmaceutical analysis, extractables/leachables and bioanalysis to support the drug development program. M-Scan Ltd was founded as an independent company in 1979 by Professor Howard R. Morris FRS (Imperial College London).
The M-Scan group currently consists of four laboratories supported by marketing offices in Europe together with agents in Korea, India and Singapore. It employs 61 highly qualified and recognized experts and generated 2009 revenue in excess of GBP 6.9 mio.
"This acquisition clearly complements our vision to become one of the top players within the Biologics testing arena (large molecules) said Chris Kirk, CEO of SGS. "The acquisition of M-Scan is a milestone in the implementation of our strategy to take advantage of the on-going, high-growth development of vaccines and monoclonal antibodies. M-Scan's global recognition, and expertise together with it's geographic footprint combined with the existing advanced analytical services in SGS Life Science provides an excellent platform for further growth and development.
M-Scan founder, Howard Morris, comments "We see compelling synergies between the respective current testing activities of M-Scan and SGS and an exciting opportunity to provide our customers with an enhanced range of services complementing our core strengths in advanced mass spectrometric and chromatographic analysis in the fields of biopharmaceutical characterization, oil/petroleum analysis and environmental monitoring."
Source: SGS Gruppe